Whitehawk Therapeutics (WHWK) EBIT (QoQ) (2010 - 2026)
Whitehawk Therapeutics (WHWK) EBIT (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - |
| 2 | Nanobiotix | 1,908.96 Bn | 1,908.90 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 474.03 Bn | 469.24 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.13 Bn | 114.88 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.96 Bn | 50.77 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn |
| 10 | Whitehawk Therapeutics | 260.33 Mn | 49.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.48% |
| Dec 31, 2025 | -27.33% |
| Sep 30, 2025 | 64.30% |
| Jun 30, 2025 | -259.76% |
| Mar 31, 2025 | 19.69% |
| Dec 31, 2024 | -41.27% |
| Sep 30, 2024 | 13.93% |
| Jun 30, 2024 | 20.13% |
| Mar 31, 2024 | -10.15% |
| Dec 31, 2023 | 0.76% |
| Sep 30, 2023 | 8.68% |
| Jun 30, 2023 | -16.17% |
| Mar 31, 2023 | -8.74% |
| Dec 31, 2022 | -2.90% |
| Sep 30, 2022 | 18.10% |
| Jun 30, 2022 | -32.91% |
| Mar 31, 2022 | 13.36% |
| Dec 31, 2021 | 81.74% |
| Sep 30, 2021 | -2,153.19% |
| Jun 30, 2021 | 5.19% |